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Abstract 
AIM: This study aimed to evaluate the importance of IFN-γ in the diagnosis of pediatric TB and LTBI and to 
compare the IFN-γ levels.  
METHODS: We analysed 100 patients examined for possible M. tuberculosis infection or disease at the Institute 
of Respiratory Diseases in Children, Kozle, Skopje. Patients were divided into 2 groups: TB disease and LTBI. 
The following parameters were analyzed: demographic characteristics, history of previous exposure to active TB, 
BCG vaccination and presence of BCG scar, lung X-ray findings, tuberculin skin test by the Monteux method and 
the value of INF-γ according to the Quantiferon TB gold test, direct samples of acid-alcohol-resistant bacilli of 
sputum and Löwenstein Jensen cultures. Informed parental consent was obtained for each child included in the 
study. 
RESULTS: In the LTBI group 60.9% had a scar from the vaccination while in the TB group 50% had BCG scar. 
TST induration diameters in children with or without BCG scar were significantly larger in patients with active TB. 
Children with active TB had significantly higher IFN-γ levels than children with LTBI. The IFN-γ for the cut-off of 
0.35 IU/ml, has 64% sensitivity for detection of LTBI, versus 80.6% sensitivity for active disease. Children with 
close TB contact had significantly higher IFN-γ levels. Correlation between TST induration diameter and IFN-γ 
levels was stronger in the TB group.  
CONCLUSION: IFN-γ levels are significantly higher in children with active TB, and children with close contact with 
TB patient. It has better sensitivity in active TB. Using both tests (IFN-γ and TST) can improve the diagnose of 
LTBI and TB in countries where vaccination with BCG is widespread. 
 
Introduction 
 
World Health Organization defines 
tuberculosis (TB) as an infectious bacterial disease 
caused by Mycobacterium tuberculosis (M. 
tuberculosis). Patients with lung tuberculosis from 
whose sputum M. tuberculosis bacilli are isolated are 
the main source of the infection. M. tuberculosis, 
which was discovered in 1882 by Robert Koch, is 
anaerobic, facultative intracellular slow-growing 
acidophilic bacillus, naturally pathogenic only in 
humans [1] [2]. In children, TB usually develops as a 
result of close family contact with smear-positive TB 
patient. 
According to WHO in 2016 there were 10.4 
million new cases with TB, and 1.8 million deaths [3]. 
Tuberculosis is a contagious/infectious disease which 
is characterised by a high rate of morbidity and 
mortality in the world. Children account for 5 to 15% of 
the cases with tuberculosis worldwide; they are more 
often infected and have more severe forms of the 
disease [4]. In the R. Macedonia in 2012 the 
prevalence was 26/100,000. In 2014, 285 new cases 
of tuberculosis were discovered, the rate is 13.8 per 
100.000 populations, which is 38 cases less in 
comparison with 2013 when the number of newly 
discovered cases amounted to 325 persons. In 2016 
the incidence was 16 per 100000 population. 
Diagnosis of tuberculosis in children is based 
on data about the history of the disease, 
epidemiologic data, clinical signs, laboratory analyses, 
x-ray examinations and immunologic examinations, 
tuberculin skin test (TST) and Interferon-Gamma 
Release Assays (IGRA) tests, while the unique secure 
proof for correct diagnosis is isolation of the causer 
from biologic material [5] [6]. Establishing the 
diagnosis in children may be difficult because the 
symptoms are often very discreet; there is not self-
recognition of the disease; direct microscopic 
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preparations are positive only in 10 to 15%; positive 
cultures are obtained in 30% of children, whereas in 
smaller age groups even less than in 20% [5] [6]. 
Latent tuberculosis infection (LTBI) is defined as a 
state of persistent immune response to stimulation by 
M. tuberculosis antigens with no evidence of clinically 
manifest active TB [7]. Common features for both TB 
and LTBI are positive TST and IGRA tests. LTBI is 
defined as an infection with tuberculous bacilli inside 
the granuloma where it remains in non-replicating 
condition but later it can be transformed into an active 
TB. However, recent experimental data support the 
dynamic model of LTBI presenting a continual 
endogenous reactivation and inflammatory response 
[8]. This has been supported by a Norwegian study 
from 2010 demonstrating that reactivation of 
tuberculosis is decreased over time [9]. The dynamic 
model offers explanation for the influence of isoniazid, 
a drug which influences the actively replicating bacilli 
only. As isoniazid prevents the episodes of 
reinfections with bacteria released from the resting 
phase, together with the delayed drainage and 
damaging of non-replicating bacteria in the stomach, 
latent infection weakens gradually [8]. The chance 
LTBI to develop into active tuberculosis during lifetime 
in infants amounts to 43%, in children at the age from 
1 to 5 years it amounts to 29%, while in children aged 
from 11 to 15 years it is15%. In children with LTBI 
younger than five years the risk of TB development 
two years after the infection is 20-40% [10] [11]. The 
risk for active TB disease after infection depends on 
several factors, and the most important is the 
immunological status [7]. Prevention of active TB 
disease by treatment of LTBI is critical component of 
the WHO End TB Strategy [12] 
The aim of this study was to evaluate the 
importance of the released IFN-γ from T lymphocytes 
IFN-γ in the diagnosis of pediatric TB and LTBI and to 
compare the IFN-γ levels between active TB and 
LTBI.  
 
 
Material and Methods 
 
In this study, we have analysed 100 patients 
with possible M. tuberculosis infection or tuberculosis 
disease who were admitted at the Institute for 
Respiratory Diseases in Children, Kozle, Skopje in the 
period from September 2014 to August 2017. In that 
period the total number of registered patients with TB 
disease in our Institute was 61, and 215 with LTBI. 
  
Inclusion criteria 
Children, aged from 1 to 15 years, with no 
history of tuberculosis disease, BCG vaccinated, with 
a history of exposure to active TB.  
In the patients included in the study the 
following parameters were analyzed: demographic 
characteristics, history of previous exposure to active 
TB and the type of contact (close, distant, unknown), 
BCG vaccination and presence of BCG scar, lung X-
ray findings, tuberculin skin test (TST) by the Mantoux 
method and the value of INF- γ according to the 
commercial Quantiferon TB gold test, direct samples 
of acid-alcohol-resistant bacilli of sputum and 
Löwenstein Jensen cultures.  
Informed parental consent was obtained for 
each child included in the study. 
Patients were divided into 2 groups:  
1. TB disease (n=36): children with 
symptoms suggestive of TB, with abnormal lung X-ray 
findings, with or without positive ARB smear 
microscopy 
2. LTBI(n=64): asymptomatic patients, 
with a history of exposure to active TB, or tuberculin 
hyperreactors, with normal lung X-ray. 
The TB group consists of 36 children, 19 
males, 17 females, and the LTBI group consists of 64 
children, 29 females and 35 males, aged from 1 to 15 
years.  
  
Exclusion criteria 
One patient with immunodeficiency and 
malnutrition, one with congenital cardiopathy and one 
with osteoarticular tuberculosis were excluded from 
the study 
 
Children (n=100) aged 1-15 years, BCG vaccinated, with positive TB contact 
Symptoms suggestive of 
TB  
yes no 
TST and INF- γ  
Chest X-ray 
normal 
LTBI (n=64) TST and INF- γ  
 
TB disease 
(n=36) 
Chest X-ray 
abnormal 
 
ARB and 
culture 
 
Figure 1: Included patients and study groups 
 
Tuberculin skin test was performed on the 
volar aspect of the left forearm by injecting 0.1 ml 
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purified protein derivative (PPD) of 5 tuberculin units 
(TU) intracutaneously. Measuring of induration 
diameter was made after 72 hours. According to the 
National tuberculosis programme, positive TST is 
considered a transversal induration diameter of more 
than 10 mm [13]. 
In our study, in patients who did not have a 
BCG vaccination scar, the value of TST diameter ≥ 6 
mm was considered as borderline for a positive skin 
test. In patients who had a BCG scar, the value of 
TST diameter ≥ 15 mm was considered as borderline 
for a positive skin test. In patients who had a BCG 
scar, the value of TST test < 15 mm was considered 
as negative [14] [15]. 
 
Figure 2: Description of performing and measuring induration in 
tuberculin skin test 
 
Quantiferon TB Gold (QFT) analysis was 
performed at the Institute for Respiratory Diseases 
and TB in line with the guidelines of the manufacturer. 
The examination was performed in two phases: the 
incubation of the whole blood with antigens was made 
in the first phase, and in the second phase the 
measuring of IFN-γ was made by the ELISA method.  
In 2-6 hours after blood taking, the test-tubes 
with blood were placed for incubation at 37ºC. 24 
hours after incubation the test-tubes had been 
centrifuged, and the plasma was separated and 
frozen at -70ºC. The concentration of INF-γ was 
measured by the ELISA method (Enzyme-Linked 
Immunosorbent Assay) using the commercial test 
Quantiferon TB gold (Cellestis, QIAGEN Company). 
The values of INF-γ were expressed in international 
units on millimetre. As recommended by the 
manufacturer, the cut-off value for a positive test was 
INF- γ ≥ 0.35 IU/ml. 
 
 
Results 
 
A total of 100 children were analysed from 
whom 36 with TB disease and 64 with Latent 
tuberculosis infection. There was no significant 
difference between the sexes in both groups. Both 
sexes were equally represented.  The age ranged 
from 1 to 15 years with an average age of 7.48 years.  
In both groups, there was no significant 
difference between young children from 1-5 years old, 
and older than 5 years.  
In the TB group, 55.6% were from the rural 
area, while in the LTBI group there was a significantly 
higher frequency of children from an urban area 
(70.3%). 
The results obtained about BCG showed that 
all 100 children were BCG vaccinated at their birth. In 
the LTBI group, 60.9% had a scar from the 
vaccination while in 39.1% of the children the BCG 
scar could not be seen. In the TB group, there was an 
equal distribution of children with or without BCG scar 
(50%-50%). 
Table 1: Basic demographic characteristics of the patients 
Parameters 
 
Children with LTBI 
(n = 64) 
Children with 
TB 
(n = 36) 
Significance 
Gender 
male 
female 
54.7% 
45.3% 
52.8% 
47.2% 
2 = 0.037 
p = 0.982 (n.s.) 
Age 
6 (IQR = 7) 
(range 1 – 15) 
5.5 (IQR = 8) 
(range 1 – 15) 
F = 0.096 
P = 0.953 (n.s.) 
Age group 
Under 5 years 
Older than 5 years 
48.4% 
51.6% 
50.0% 
50.0% 
2 = 0.453 
p = 0.797 (n.s.) 
Area 
Rural 
Urban 
29.7% 
70.3% 
55.6% 
44.4% 
2 = 6.821 
p = 0.033 (*) 
BCG scar 
Yes 
No 
60.9% 
39.1% 
50.0% 
50.0% 
2 = 1.587 
p = 0.452 (n.s.) 
 
According to the contact with a patient 
infected with active TB, our results showed that there 
is a significantly higher per cent of children with very 
close contact with active TB in the TB group. All of the 
children had a chest X-ray. In the LTBI group, all of 
them showed normal findings. In the TB group, chest 
X-rays were mostly with primary TB. 
Direct specimens for acid-alcohol-resistant 
bacilli (ARB) from sputum as well as culture in the 
solid medium by Löwenstein Jensen were analysed in 
all children with active TB. Most of them, 88.9% were 
ARB negative, and only 11.1% ARB positive. 
Löwenstein Jensen cultures were positive in 22.2% of 
the TB cases and negative in the rest of them 
(77.8%). In the group of patients with LTBI most of the 
children, 89.1% were not analysed for ARB and 
Löwenstein Jensen culture. In only 10.9% of children, 
these analyses were performed and were all negative.  
Table2: Specific characteristics in children with TB and LTBI 
Parameters 
Children with LTBI 
(n = 64) 
Children with 
TB 
(n = 36) 
Significance 
Contact with active TB 
Close 
Distant 
Unknown 
48.4% 
46.9% 
4.7% 
75.0% 
19.4% 
5.6% 
2 = 7.523 
p = 0.023 (*) 
Chest X-ray findings 
Normal 
TB pleuritis 
Primary TB 
Cavities 
Hilar lymphadenitis 
100.0% 
0.0% 
0.0% 
0.0% 
0.0% 
 
0.0% 
8.3% 
77.8% 
5.6% 
8.3% 
2 = 100.000 
p = 9.87·10
-21
(**) 
ARB 
positive 
negative 
Not analyzed 
0.0% 
10.9% 
89,1% 
11.1% 
88.9% 
0,0% 
2 = 75.071 
p = 4.99·10
-17
(**) 
Löwenstein–Jensen culture 
Positive 
Negative 
Not analyzed 
0.0% 
10.9% 
89.1% 
22.2% 
77.8% 
0.0% 
2 = 75.694 
p = 3.66·10
-17
(**) 
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TST induration diameters in children with or 
without BCG scar were significantly larger in patients 
with active TB (Table 3 and 4). 
Table 3: TST in children with BCG scar 
Parameter 
Children with LTBI 
(n = 39) 
Children with TB 
(n = 18) 
Significance 
Children with BCG scar 
ТST induration diameter 
(mm) 
8 
(IQR = 11, range 3 – 
24) 
20 
(IQR = 5, range 4 – 
27) 
Mann-Whitney 
test: U = 121.0 
p = 0.00008(**) 
 
In all 100 children, IFN-γ was measured with 
commercial Quantiferon TB gold test.  
Table 4: TST in children without BCG scar 
Parameter 
Children with LTBI 
(n = 25) 
Children with TB 
(n = 18) 
Significance 
Children without BCG scar 
ТST induration diameter 
(mm) 
9 
(IQR =13; range 2 – 
34) 
15 
(IQR = 7; range 3 – 
24) 
Mann-Whitney 
test:U = 135.5 
p = 0.027(*) 
 
In this study, the IFN-γ for the cutoff of 0.35 
IU/ml, had 64% sensitivity for detection of LTBI, 
versus 80.6% sensitivity for active disease. 
In our results, the Kruskal-Wallis test showed 
statistically highly significant differences in the levels 
of IFN-γ (IU/ml) among the two groups of patients. 
The Mann-Whitney tests confirmed that children with 
active TB have significantly higher IFN-γ levels than 
children with LTBI, (U = 649.5; **p = 0.0003). 
Table 5: IFN-γ levels (IU/ml) 
Parameter 
Children with LTBI 
(n = 64) 
Children with TB Significance 
Levels of IFN-γ (IU/mL) 
0.475 
(IQR = 1.082) 
(range 0.030 – 
3.042) 
2.037 
(IQR = 2.246) 
(range 0.024 – 
4.764) 
Kruskal-Wallis test: F 
= 46.042 
p = 1.00·10
-10
(**) 
The test was considered positive with titer ≥ 0.35 IU/ml. 
 
According to that cutoff, there was the 
significantly higher frequency of patients with a 
positive test in the TB group (80.6%) compared with 
the LTBI group (64.1%; 
2
 = 3.984, *p = 0.047)  
 
Figure 3: significantly higher frequency of patients with a positive 
test in the TB group (*p < 0.05) 
In this study, we determined a new cut-off 
diagnostic value of IFN-γ level and its sensitivity and 
specificity for distinguishing LTBI from active TB in 
children in R. Macedonia. This was analysed with 
Receiver operating characteristic (ROC) curve.  
Our analyses showed that IFN-γ level ≥ 0.822 
IU/mL is optimal to discriminate children with LTBI and 
TB disease, with 74.3% sensitivity and 67.2% 
specificity (25.7% false negative and 32.8% false 
positive findings). 
 
Figure 4: ROC analyses for determination of the cutoff diagnostic 
value of IFN-γ (IU/mL) for distinguishing children with TB disease 
from LTBI  
 
About the influence of the age on IFN-γ 
levels, our results showed weak but statistically 
significant (*p = 0.013) and a positive correlation 
between the age and IFN-γ levels in both groups 
Correlation between TST induration diameter and 
IFN-γ levels was stronger in the group of children with 
active TB. We also compared the IFN-γ levels 
according to the contact with active TB patient. 
As we can see from Table 6, patients with 
close contact have significantly higher IFN-γ levels (*p 
= 0.002).  
Table 6: Comparison of the IFN-γ levels according to the 
contact with active TB patient 
Parameter 
Close contact 
(n = 58) 
Distant contact 
(n = 37) 
Significance 
IFN-γ (IU/mL) 
1.54 
(IQR = 2.44) 
(range 0.04 – 4.76) 
0.41 
(IQR = 0.70) 
(range 0.02 – 4.47) 
Mann-Whitney 
test: U = 666.0 
p = 0.002 (*) 
 
 
 
Discussion 
 
When we speak about the eradication of TB, it 
is not enough only to treat patients with active 
tuberculosis but to diagnose and to treat adequately 
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those with LTBI. 
Until recently, tuberculin skin test by the 
Mantoux method has been the uniquely available 
immunologic test for diagnosis of LTBI. It is an in vivo 
test that is based on measurement of the reaction of 
postponed hypersensitivity after injecting a mixture of 
mycobacterial antigens, PPD subcutaneously on the 
forearm [16]. PPD of 5 tuberculin units (TU) is used in 
our country. The size of induration on the site of 
injection is proportional to the strength of the 
immunologic response to competent cells. Induration 
diameter is read after 72 hours [17]. 
A positive outcome can be expected if two to 
eight weeks have passed after the infection with M. 
tuberculosis. Since the solution of PPD contains more 
than 200 protein components that are common for 
most of the mycobacteria, tuberculin test may give 
false-positive results in persons vaccinated with BCG 
or who were in contact with nontuberculous 
mycobacteria [18]. 
False-negative results may be found in 
persons with damaged or immature cell immunity 
such as patients infected with HIV, patients with 
iatrogenic-caused immunosuppression, children in 
younger age due to weak reactivity on the skin or if 
the result is falsely read as negative [19]. 
According to the above said it is clear that 
TST is not a secure test for detecting LTBI especially 
in countries where there is BCG vaccination such as 
in our country. In our study, TST induration diameters 
in children with or without BCG scar were significantly 
larger in patients with active TB. 
Since 2004 the Quantiferon TB gold test has 
been used, and it has largely contributed to the 
diagnosis of LTBI and TB. The specific antigens that 
are used in this test are early secreted antigenic 
target-6KD (ESAT-6), culture filtrate protein-10KD 
(CFR-10) and TB 7.7. These antigens do not exist in 
BCG (Bacillus Calmette-Guerin) and most of the 
nontuberculous mycobacteria, except in M. Kansai, M. 
szulgai, M. marinum, M. flavescens and M. gastric 
[20]. Therefore, the chance of having false-positive 
results of IGRA tests is very small since T 
lymphocytes in healthy BCG-vaccinated uninfected 
persons as well as in those infected by 
nontuberculous mycobacteria do not secrete gamma 
interferon after stimulation with the mixture of antigens 
ESAT-6, CFP-10 and TB 7.7 [21]. 
The positive features of IGRA tests are their 
high diagnostic sensitivity and specificity, 
reproducibility and possible standardisation. The 
research of Pai et al., (2008) showed 99% specificity 
of Quantiferon TB gold test in persons who were not 
BCG-vaccinated and 96% in BCG-vaccinated 
persons, while the sensitivity reached 78% [22]. Sun 
et al., found a sensitivity for all TB disease in children 
of 70% for ELISA (range: 57%–96%), 62% for 
ELISPOT (range: 40%–100%), and 71% for the TST 
(range: 43%–100%) [23]. In our study, the IFN-γ for 
the cutoff of 0,35 IU/ml, had 64% sensitivity for 
detection of LTBI, versus 80,6% sensitivity for active 
disease.  
Regarding IFN-γ levels differences in children 
with LTBI and active TB, Whittaker et al., [24] 
described a lower amount of IFN-γ in LTBI patients 
compared to active TB, whereas Latorre et al. 
described no significant difference between these two 
groups [25]. Our results showed statistically highly 
significant differences in the levels of IFN-γ (IU/ml) 
among the two groups of patients. Children with active 
TB had significantly higher IFN-γ levels than children 
with LTBI (U = 649.5; **p = 0.0003). Connell et al., in 
2 subsequent studies, showed a good agreement 
between positive IGRAs and TB disease, whereas a 
poor correlation between IGRAs and TST for the 
diagnosis of LTBI in children was found [26] [27]. 
 About the influence of the age on IFN-γ 
levels, our results showed weak but statistically 
significant (*p = 0.013) and a positive correlation 
between the age and IFN-γ levels in both groups. 
Nakaoka et al. reported a decreased response to QFT 
in children < 5 years of age [28]. 
Correlation between TST induration diameter 
and IFN-γ levels was stronger in the group of children 
with active TB. Onur at al. reported that QFT positivity 
differed signiﬁcantly according to TST induration 
diameter and the positivity rate was signiﬁcantly 
higher in patients with an induration diameter of 10–14 
and ≥ 15 mm compared to other diameters [29]. In our 
study, we also compared the IFN-γ levels in patients 
with close or distant contact with active TB. The 
results showed that patients with close contact have 
significantly higher IFN-γ levels (*p = 0.002). Kang et 
al., found the positive QFT rates 4%, 10%, 44% and 
81% in low risk, casual contact, close contact, and 
active TB patients, respectively [30]. 
The limitations of this study are that we hadn’t 
investigated children without risk of TB infection, so 
we couldn’t make a correlation between IFN-γ levels 
in healthy children and children with LTBI and 
determine a new cut-off value of IFN-γ that can 
distinguish children with LTBI from healthy controls. 
The specificity of IFN-γ couldn’t be analysed too. 
In conclusion, the present study indicates that 
IFN-γ levels are significantly higher in children with 
active TB, and children with close contact with TB 
patient. It has better sensitivity in active TB, and the 
correlation between TST induration diameter and IFN-
γ levels is stronger in children with active TB versus 
children with LTBI. Using both tests (IFN-γ and TST) 
can improve the diagnose of LTBI in children in 
countries like R. Macedonia where vaccination with 
BCG is widespread. According to our results that IFN-
γ has better sensitivity and stronger correlation with 
TST inactive TB, these tests can contribute to better 
and certain diagnose of TB disease, because of a lack 
of microbiological proof for M. tuberculosis in children. 
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